781
Views
11
CrossRef citations to date
0
Altmetric
Endocrinology

Mapping AcroQoL scores to EQ-5D to obtain utility values for patients with acromegaly

, , , , , ORCID Icon, & show all
Pages 382-389 | Received 23 Oct 2017, Accepted 14 Dec 2017, Published online: 05 Jan 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yanitsa Rusenova, Silvia Vandeva, Atanaska Elenkova, Guenka Petrova & Maria Kamusheva. (2022) Quality of life of patients with acromegaly: comparison of different therapeutic modalities. Expert Opinion on Orphan Drugs 10:1, pages 48-54.
Read now

Articles from other publishers (10)

Qing Yang, Long Lin Jiang, Yin Feng Li & Deyu Huang. (2023) Prediction of the SF-6D utility score from Lung cancer FACT-L: a mapping study in China. Health and Quality of Life Outcomes 21:1.
Crossref
Lisa Caulley, Eline Krijkamp, Mary-Anne Doyle, Kednapa Thavorn, Fahad Alkherayf, Nick Sahlollbey, Selina X. Dong, Jason Quinn, Stephanie Johnson-Obaseki, David Schramm, Shaun J. Kilty & Myriam G. M. Hunink. (2022) Cost-effectiveness of direct surgery versus preoperative octreotide therapy for growth-hormone secreting pituitary adenomas. Pituitary 25:6, pages 868-881.
Crossref
Roberto Salvatori, Pietro Maffei, Susan M. Webb, Thierry Brue, Jane Loftus, Srinivas Rao Valluri, Roy Gomez, Michael P. Wajnrajch & Maria Fleseriu. (2022) Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experience. Pituitary 25:3, pages 420-432.
Crossref
S. Camerini, A. Wennberg, M. Adriani, B. Martin, R. Vettor, P. Maffei & F. Dassie. (2022) Questionnaire and tools: clinical powerful instrument in acromegaly diagnosis and management. Journal of Endocrinological Investigation 45:10, pages 1823-1834.
Crossref
Naoki Yamamoto, Shin Urai, Hidenori Fukuoka, Masaaki Yamamoto, Kenichi Yoshida, Masaki Suzuki, Hiroki Shichi, Yasunori Fujita, Keitaro Kanie, Genzo Iguchi, Yutaka Takahashi & Wataru Ogawa. (2022) The Effect of Aging on Quality of Life in Acromegaly Patients Under Treatment. Frontiers in Endocrinology 13.
Crossref
Kailu Wang, Xiaopeng Guo, Siyue Yu, Lu Gao, Zihao Wang, Huijuan Zhu, Bing Xing, Shuyang Zhang & Dong Dong. (2021) Mapping of the acromegaly quality of life questionnaire to ED-5D-5L index score among patients with acromegaly. The European Journal of Health Economics 22:9, pages 1381-1391.
Crossref
Merel van der Meulen, Amir H. Zamanipoor Najafabadi, Daniel J. Lobatto, Cornelie D. Andela, Thea P. M. Vliet Vlieland, Alberto M. Pereira, Wouter R. van Furth & Nienke R. Biermasz. (2020) SF-12 or SF-36 in pituitary disease? Toward concise and comprehensive patient-reported outcomes measurements. Endocrine 70:1, pages 123-133.
Crossref
Michela Meregaglia, Amanda Whittal, Elena Nicod & Michael Drummond. (2020) ‘Mapping’ Health State Utility Values from Non-preference-Based Measures: A Systematic Literature Review in Rare Diseases. PharmacoEconomics 38:6, pages 557-574.
Crossref
Clara Mukuria, Donna Rowen, Sue Harnan, Andrew Rawdin, Ruth Wong, Roberta Ara & John Brazier. (2019) An Updated Systematic Review of Studies Mapping (or Cross-Walking) Measures of Health-Related Quality of Life to Generic Preference-Based Measures to Generate Utility Values. Applied Health Economics and Health Policy 17:3, pages 295-313.
Crossref
Mônica R Gadelha, Leandro Kasuki, Dawn S T Lim & Maria Fleseriu. (2019) Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update. Endocrine Reviews 40:1, pages 268-332.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.